Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study

View/ Open
Issue date
2016Author
Gómez Peralta, Fernando
Abreu, Cristina
Valls Marsal, Joan
Mestre, Olga
Romero, Odile
Martínez González, María Dolores
Sampol, Gabriel
Ciudin, Andreea
Hernández, Cristina
Simó, Rafael
Suggested citation
Lecube Torelló, Albert;
Sánchez Peña, Enric;
Gómez Peralta, Fernando;
Abreu, Cristina;
Valls Marsal, Joan;
Mestre, Olga;
...
Simó, Rafael.
(2016)
.
Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study.
Plos One, 2016, vol. 11, núm. 6, e0157579.
https://doi.org/10.1371/journal.pone.0157579.
Metadata
Show full item recordAbstract
Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However,
it is unknown whether T2D affects daily somnolence and quality of sleep independently of
the impairment of polysomnographic parameters.
Material and Methods
A case-control study including 413 patients with T2D and 413 non-diabetic subjects, matched
by age, gender, BMI, and waist and neck circumferences. A polysomnography was performed
and daytime sleepiness was evaluated using the Epworth Sleepiness Scale (ESS). In addition,
135 subjects with T2D and 45 controls matched by the same previous parameters were
also evaluated through the Pittsburgh Sleep Quality Index (PSQI) to calculate sleep quality.
Results
Daytime sleepiness was higher in T2D than in control subjects (p = 0.003), with 23.9% of subjects
presenting an excessive daytime sleepiness (ESS>10). Patients with fasting plasma
glucose (FPG 13.1 mmol/l) were identified as the group with a higher risk associated with
an ESS>10 (OR 3.9, 95%CI 1.8–7.9, p = 0.0003). A stepwise regression analyses showed
that the presence of T2D, baseline glucose levels and gender but not polysomnographic parameters (i.e apnea-hyoapnea index or sleeping time spent with oxigen saturation lower
than 90%) independently predicted the ESS score. In addition, subjects with T2D showed
higher sleep disturbances [PSQI: 7.0 (1.0–18.0) vs. 4 (0.0–12.0), p<0.001].
Conclusion
The presence of T2D and high levels of FPG are independent risk factors for daytime
sleepiness and adversely affect sleep quality. Prospective studies addressed to demonstrate
whether glycemia optimization could improve the sleep quality in T2D patients
seem warranted.
Related resource
http://hdl.handle.net/10459.1/57632Is part of
Plos One, 2016, vol. 11, núm. 6, e0157579European research projects
Collections
The following license files are associated with this item: